Integrated analysis of in vivo retinal perivascular amyloid imaging and cognition
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Mitzi Gonzales und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Retina, Plaque, Amyloid, Cognition. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH/NIA, NIA NIH HHS, Saban Private Foundation.
Abstract (Originalsprache)
INTRODUCTION Given the close interactions between the retina and the brain, retinal amyloid imaging may serve as a diagnostic and prognostic tool for Alzheimer's disease and related dementias. This retrospective study investigated multivariable associations between retinal perivascular amyloid and cognitive domains. METHODS Integrated analysis of retinal perivascular amyloid imaging, neuropsychological assessment, and brain magnetic resonance imaging in adults with and without cognitive impairment ( N = 26; mean age: 65 ± 7 years; 50% female). Correlations between perivascular amyloid plaque burden and cognitive domains were evaluated with linear regression and interactions with hippocampal volumetry were explored. RESULTS Higher perivascular and periarteriolar amyloid plaque count in the secondary small and tertiary branches were associated with poorer verbal and visual memory in this cohort ( p = 0.005–0.009). Higher perivascular amyloid burden interacted with hippocampal atrophy to worsen visual memory ( p = 0.033). DISCUSSION Retinal perivascular amyloid may serve as a non‐invasive marker for cognitive impairment and may shed insight into pathological changes in the brain. Highlights In vivo retinal perivascular amyloid plaque counts are associated with poorer memory. Retinal perivascular amyloid interacted with hippocampal atrophy to worsen memory. Retinal amyloid imaging is a potential biomarker for neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Department of Neurosurgery, Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Department of Physical Medicine & Rehabilitation, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute of the Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
- Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
- Department of Biomedical Sciences, Division of Applied Cell Biology and Physiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Förderung
- NIH/NIA
- NIA NIH HHS
- Saban Private Foundation
- The Hertz Innovation Fund
- Gordon, Jona Goldrich
Zitieren
APA
Gonzales, M., Fuchs, D. T., Doustar, J., Koronyo, Y., Sherman, D. S., Lyden, P. D., Sicotte, N. L., Black, K. L., Kremen, S., Dumitrascu, O. M., & Koronyo-Hamaoui, M. (2025). Integrated analysis of in vivo retinal perivascular amyloid imaging and cognition. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70366
Vancouver
Gonzales M, Fuchs DT, Doustar J, Koronyo Y, Sherman DS, Lyden PD, et al. Integrated analysis of in vivo retinal perivascular amyloid imaging and cognition. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70366
BibTeX
@article{Gonzales2025,
author = {Gonzales, Mitzi and Fuchs, Dieu-Trang and Doustar, Jonah and Koronyo, Yosef and Sherman, Dale S and Lyden, Patrick D and Sicotte, Nancy L and Black, Keith L and Kremen, Sarah and Dumitrascu, Oana M and Koronyo-Hamaoui, Maya},
title = {Integrated analysis of in vivo retinal perivascular amyloid imaging and cognition},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70366}
}
EUVIMED